Ivermectin useful for treating mild COVID-19
A 5-day course of the Food and Drug Administration-approved antiparasitic agent ivermectin appears safe and effective in the treatment of adult patients with early-onset mild COVID-19, a study has reported.
Ivermectin useful for treating mild COVID-19
11 Feb 2021
